Please send along any corrections or additions to me at Email.
Here, of interest, is a listing of the eighteen largest pharmaceutical companies as ranked 21 years ago (in 1987). The source is an extremely odd, but interesting book : "Murder By Injection" by Eustace Mullins.
- Merck (U.S.) $4.2 billion in sales.
- Glaxo Holdings (United Kingdom) $3.4 billion.
- Hoffman LaRoche (Switzerland) $3.1 billion.
- Smith Kline Beckman (U.S.) $2.8 billion.
- Ciba-Geigy (Switzerland) $2.7 billion.
- Pfizer (U.S.) $2.5 billion (Standard & Poor's gives its sales as $4 billion.)
- Hoechst A. G. (Germany) $2.5 billion (Standard & Poor's lists its sales as $38 Billion Deutschmarks).
- American Home Products ( U.S.) $2.4 billion ($4.93 billion according to Standard & Poor's).
- Lilly (U.S.) $2.3 billion ($3.72 billion Standard & Poor's).
- Upjohn ( U.S.) $2 billion.
- Squibb (U.S.) $2 billion.
- Johnson & Johnson ( U.S.) $1.9 billion.
- Sandoz (Switzerland) $1.8 billion.
- Bristol Myers (U.S.) $1.6 billion.
- Beecham Group (United Kingdom) $1.4 billion (Standard & Poor's gives $1.4 billion in sales of the U.S. subsidiary $2.6 billion pounds sterling as overall income).
- Bayer A. G. (Germany) $1.4 bilIion (Standard & Poor's gives the figure as $45.9 billion Deutschmarks).
- Syntex (U.S.) $1.1 billion.
- Warner Lambert (U.S.) $1.1 billion (Standard & Poor's gives the figure as $3.1 billion).
I received a huge number of helpful responses including this one:
From: "World Changer" firstname.lastname@example.org
CC: John Kaminski email@example.com, JB Campbell firstname.lastname@example.org, Christopher Bollyn email@example.com, Prothink@yahoo.com, Counter Bias firstname.lastname@example.org
Subject: Pharmaceutical Mergers - Scientific Misconduct Wiki
Date: Tue, 2 Sep 2008 14:19:18 -0500
The main thing you need to do with your list is to list all the Jews who own and run the companies.
Given the recent revelations that George Bush is Jewish and attended Sheffield University, can anyone help with the vital task of collating ethnic affiliations of current pharmaceutical CEO's?
Labels: pharmaceutical industry